FNY Investment Advisers’s Alder Biopharmaceuticals ALDR Stock Holding History

FNY Investment Advisers’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-51,400	Closed	-$969K	–	1219
2019 Q3	$969K	Buy	+51,400	New	+$588K	0.3%	50
2019 Q2	–	Sell	-37,023	Closed	-$505K	–	1223
2019 Q1	$505K	Buy	+37,023	New	+$480K	0.17%	78

FNY Investment Advisers's ALDR Position: Q4 2019 in Review

FNY Investment Advisers sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 51,400 shares — an estimated $969K sold.

FNY Investment Advisers first reported a position in ALDR in Q1 2019 and held it in 2 quarters. The position peaked at $969K in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

FNY Investment Advisers reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
FNY Investment Advisers sold 51,400 Alder Biopharmaceuticals shares in Q4 2019, an estimated $969K.
FNY Investment Advisers first reported a position in Alder Biopharmaceuticals in Q1 2019 and held it in 2 quarters.
FNY Investment Advisers's Alder Biopharmaceuticals position peaked at $969K in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on FNY Investment Advisers's 13F filing for Q4 2019, filed 10 Jan 2020.